Denali Therapeutics Inc

DNLINASDAQ · US

Holders

REDUCEDStale
Chin Peter Scott
Denali Therapeutics Inc · NASDAQ
−1,654 sh · $36.9K
Filed 9 Sept 2026SEC Form 4view source
REDUCEDStale
Thornberry Nancy
Denali Therapeutics Inc · NASDAQ
−615 sh · $14.6K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Thornberry Nancy
Denali Therapeutics Inc · NASDAQ
−10,824 sh · $247.3K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Schuth Alexander O.
Denali Therapeutics Inc · NASDAQ
−2,768 sh · $64.9K
Filed 3 Sept 2026SEC Form 4view source
DISCLOSEDStale
Polen Capital Management
Denali Therapeutics Inc · NASDAQ
65,301 sh · $1.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Denali Therapeutics Inc · NASDAQ
26,900 sh · $444.1K
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Denali Therapeutics Inc · NASDAQ
13,174,562 sh · $305.9M
Filed 30 Jun 2024SEC 13Fview source